Stockscreener 앱 받기
1.17
2.50%
-0.03
시간 외 거래:
1.18
0.01
+0.85%
전일 마감가:
$1.20
열려 있는:
$1.2
하루 거래량:
182.73K
Relative Volume:
1.21
시가총액:
$44.78M
수익:
$135.87M
순이익/손실:
$72.20M
주가수익비율:
1.3929
EPS:
0.84
순현금흐름:
$45.09M
1주 성능:
-9.30%
1개월 성능:
-26.88%
6개월 성능:
-57.76%
1년 성능:
-27.78%
1일 변동 폭
$1.16
$1.21
1주일 범위
$1.16
$1.37
52주 변동 폭
$1.16
$3.07
Scynexis Inc Stock (SCYX) Company Profile
명칭
Scynexis Inc
전화
201-884-5485
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
SCYX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SCYX | 1.17 | 44.78M | 135.87M | 72.20M | 45.09M | 0.84 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-22 | 개시 | Guggenheim | Buy |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-07-11 | 업그레이드 | Needham | Hold → Buy |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2017-07-10 | 개시 | ROTH Capital | Buy |
| 2017-05-09 | 다운그레이드 | Needham | Buy → Hold |
| 2017-03-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-20 | 개시 | H.C. Wainwright | Buy |
| 2016-10-07 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | 재개 | Brean Capital | Buy |
| 2016-08-17 | 개시 | Guggenheim | Buy |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-08-09 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | 개시 | Brean Capital | Buy |
| 2015-12-29 | 개시 | WBB Securities | Speculative Buy |
| 2015-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-06-10 | 개시 | Needham | Buy |
| 2014-05-29 | 개시 | Canaccord Genuity | Buy |
| 2014-05-29 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Scynexis Inc 주식(SCYX)의 최신 뉴스
Avidity Partners Management LP's Strategic Acquisition in SCYNEX - GuruFocus.com
Federated Hermes, Inc. Increases Stake in SCYNEXIS Inc - GuruFocus.com
SCYX stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
SCYX stock touches 52-week low at $1.25 amid market challenges - Investing.com
SCYNEXIS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Scynexis Inc earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada
SCYNEXIS announces new $50 million equity sales agreement By Investing.com - Investing.com Nigeria
Scynexis: Q3 Earnings Snapshot - San Francisco Chronicle
SCYNEXIS announces new $50 million equity sales agreement - Investing.com India
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
SCYNEXIS Secures $10M GSK Milestone, Advances Antifungal Pipeline Despite Q3 Revenue Dip | SCYX Stock News - StockTitan
SCYNEXIS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. In - GuruFocus.com
Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 89% over the last five years - Yahoo Finance
SCYNEXIS (NASDAQ:SCYX) Shares Pass Above Fifty Day Moving AverageShould You Sell? - MarketBeat
SCYNEXIS (NASDAQ:SCYX) Stock Price Passes Below Two Hundred Day Moving AverageHere's Why - MarketBeat
SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Federated Hermes, Inc. Expands Stake in SCYNEXIS Inc - Yahoo Finance
SCYNEXIS (NASDAQ:SCYX) Share Price Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024 - The Manila Times
SCYNEXIS (NASDAQ:SCYX) Shares Pass Below 200 Day Moving Average of $1.82 - MarketBeat
CRISPR Therapeutics: Prepare To Be Bored (NASDAQ:CRSP) - Seeking Alpha
Potential Price Increase for Synopsys, Inc. (SNPS) After Recent Insider Activity - Knox Daily
Scynexis CEO acquires $27,400 in company stock By Investing.com - Investing.com Canada
Syncona Advances Share Buyback, Bolsters Treasury Shares - TipRanks
Xero buys South African firm for $115m in 'departure' - New Zealand Herald
SCYNEXIS, Inc. (NASDAQ:SCYX) CEO Gonzalez David Angulo Buys 20,000 Shares - MarketBeat
Scynexis CEO acquires $27,400 in company stock - Investing.com
Synectics says trading is 'significantly ahead' of previous guidance - Proactive Investors USA
Better than expected profits forecast for security tech company - The Business Desk
Synopsys Inc. stock rises Friday, still underperforms market - MarketWatch
SCYNEXIS (NASDAQ:SCYX) Stock Crosses Below 200-Day Moving Average of $1.83 - MarketBeat
SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook - TipRanks
SCYNEXIS (NASDAQ:SCYX) Shares Cross Below 200-Day Moving Average of $1.84 - MarketBeat
SCYX stock touches 52-week low at $1.35 amid market challenges - Investing.com
Financial Fitness Check: Examining Scynexis Inc (SCYX)’s Key Ratios - The Dwinnex
SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
SCYNEXIS (NASDAQ:SCYX) Downgraded by StockNews.com to Sell - Defense World
SCYNEXIS (NASDAQ:SCYX) Downgraded to "Sell" at StockNews.com - MarketBeat
SCYNEXIS Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Scynexis: Q2 Earnings Snapshot - San Antonio Express-News
SCYNEXIS Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt? - Simply Wall St
Acadian Asset Management LLC Purchases 21,700 Shares of SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World
SCYNEXIS secures $10 million milestone from GSK - Investing.com India
Scynexis Inc (SCYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.15%
자본화:
|
볼륨(24시간):